Platinum-resistant Ovarian Cancer Unknown Status Phase 2 Trials for Niraparib (DB11793)

Also known as: Platinum drug resistant Ovarian cancer / Platinum-resistant Ovarian Cancer (PROC) / Platinum Resistant Ovarian Cancer

IndicationStatusPhase
DBCOND0068919 (Platinum-resistant Ovarian Cancer)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04376073Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian CancerTreatment